Kansas City, MONCT06906341Now EnrollingIRB Ready

Ovarian Cancer Clinical Trial in Kansas City, MO

Access cutting-edge ovarian cancer treatment through this clinical trial at a research site in Kansas City. Study-provided care at no cost to qualified participants.

Sponsored by Corcept Therapeutics

Quick Self-Assessment

See if you qualify for this Kansas City location

Preparing your pre-screening questions...

Expert Care in Kansas City

Access ovarian cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related ovarian cancer treatment provided free

Apply for This Kansas City Location

Check if you qualify for this ovarian cancer clinical trial in Kansas City, MO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Kansas City

    Convenient for MO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Kansas City site if eligible
  4. 4Begin participation

About This Ovarian Cancer Study in Kansas City

This is a Phase 2, single-arm, open-label study to evaluate efficacy and safety of intermittent dosing of relacorilant in combination with nab-paclitaxel and bevacizumab in patients with ovarian cancer.

Sponsor: Corcept Therapeutics

Who Can Participate

Inclusion Criteria

Histologic diagnosis of high-grade serous/endometrioid, epithelial ovarian, primary peritoneal, or fallopian-tube carcinoma.
Platinum-resistant disease (defined as progression \<183 days from the last dose of platinum).
At least 1 measurable (target) lesion per RECIST version 1.1.
Life expectancy of ≥3 months.
Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1.
Able to swallow and retain oral medication and does not have uncontrolled emesis.
1 to 3 lines of prior systemic anticancer therapy for ovarian cancer. 1. ≥1 prior line of platinum-based therapy. 2. Prior treatment with bevacizumab allowed.
Adequate organ function meeting the following laboratory-test criteria: 1. Absolute neutrophil count (ANC) ≥1500 cells/mm\^3. 2. Platelet count ≥100,000/mm\^3. 3. Hemoglobin ≥9 g/dL. 4. Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) ≤2.5 × upper limit of normal (ULN), or ≤5 × ULN if liver metastases. 5.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Kansas City?

Yes, this clinical trial (NCT06906341) has an active research site in Kansas City, MO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Ovarian Cancer Treatment Options in Kansas City, MO

If you're searching for ovarian cancer treatment options in Kansas City, MO, this clinical trial (NCT06906341) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Kansas City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ovarian cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all ovarian cancer clinical trials near you to find additional studies recruiting in your area.

More Ovarian Cancer Trials in Kansas City, MO

See all ovarian cancer clinical trials recruiting in Kansas City — not just this study.

Browse Ovarian Cancer Trials in Kansas City →

Browse More Trials by Condition

Ovarian Cancer TrialsAll Conditions →

Ready to Join in Kansas City?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Kansas City, MO